The dichloromethane extract of the dried fruits of Chaenomeles speciosa (Sweet) Nakai (Rosaceae) showed strong inhibitory activity against both prostaglandin-H-synthase isoenzymes [IC 50 (PGHS-1) = 5.1 µg/mL; IC 50 (PGHS-2) = 2.3 µg/mL]. The lipophilic portion of the extract was mainly responsible for the inhibitory effect. Several triterpenoid acids were isolated and identified as contributing to this inhibitory activity (oleanolic, pomolic, 3β-O-acetylursolic and 3β-O-acetylpomolic acids). Comparison of their inhibitory potential with their selectivity to PGHS-2 showed that 3β-O-acetylursolic acid had the highest potency in the inhibition of PGHS-1 and PGHS-2 enzymes, whilst pomolic and 3β-O-acetylpomolic acid, with a hydroxyl group at position 19α, showed selectivity for PGHS-2. The inhibitory effect of the extract seems to be the result of the activity of the mixture of these different triterpenoid acids.
Prostaglandin-H-synthase (PGHS) catalyses the first two steps of the formation of prostaglandins (PG) from arachidonic acid, with a fatty acid cyclooxygenase activity (catalyzing the reaction from arachidonic acid to PGG 2 ) and a PG hydroperoxidase activity (catalyzing the reaction from PGG 2 to PGH 2 ). The enzyme exists in two isoforms: the constitutive PGHS-1, which is responsible for 'housekeeping' purposes, like the formation of protective PGs in the stomach and the kidneys, while PGHS-2 is mainly induced at sites of inflammation to form inflammatory PGs, mainly PGE 2 [1] . PGE 2 is a common marker for the determination of inflammation [2] . Therefore, PGHS is an important target of anti-inflammatory drug research. While common non-steroidal anti-inflammatory drugs act as unspecific inhibitors of both isoenzymes, the selective inhibition of PGHS-2 is the goal of new NSAIDs. They are expected to have less side effects on the stomach and the kidneys [3] , even if it is known that long-term treatment with COX-2selective drugs (rofecoxib) for cancer prevention suggested an elevated incidence of myocardial infarction after long term use [4] .
The dried fruits of Chaenomeles speciosa (Sweet) Nakai ("Mugua"), Rosaceae, are used as an antiinflammatory and antirheumatic drug in traditional Chinese medicine. The dichloromethane-extract of Mugua was tested for its inhibitory potential on prostaglandin synthesis in PGHS-1/-2 screening assays. We now report on the bioassay-guided fractionation and the identification of the PGHSinhibitory active principles.
The fruits of C. speciosa were powdered and extracted with dichloromethane. The extract, when tested in PGHS-1 and -2 microtiter assays with EIA evaluation [5] , showed very strong inhibition of both isoenzymes. The IC 50 values were determined to be 5.1 µg/mL for PGHS-1 and 2.3 µg/mL for PGHS-2. The extract showed slight preferential inhibition of PGHS-2. When fractionated by vacuum liquid chromatography (VLC) with different mixtures of n-hexane/ethylacetate of increasing polarity there was a clear preference of inhibitory potential by the lipophilic part of the extract (Figure 1 ). From this part we isolated and identified different triterpenoid acids as the major constituents. The structures have been established on the basis of their spectral data (IR, EI-MS, DCI-MS, 1 H NMR, 13 C NMR) and by comparison with literature data [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] as 3β-O-acetylursolic acid, 3β-O-acetylpomolic acid, oleanolic acid, pomolic acid, euscaphic acid, tormentolic acid and pirolonic acid. The acids, reported for the first time from C. speciosa, were tested for their inhibitory activity of PGHSisoenzymes (Table 1 ). Most exhibited inhibition of both enzymes. Only euscaphic acid showed high inhibitory potential for PGHS-2. Separation of euscaphic and tormentolic acid was not achieved, so their inhibition values are derived from enriched fractions (ca. 90% purity). The IC 50 values of the major triterpenoid acids are listed in Table 2 .
3β-O-acetylursolic acid turned out to be the most potent inhibitor, while oleanolic acid showed only weak inhibition of both isoenzymes. When calculating the inhibition ratio PGHS-1/PGHS-2, pomolic acid and 3β-O-acetylpomolic acid showed more pronounced inhibitory activity against PGHS-2 than on PGHS-1. Both constituents possess a hydroxyl moiety in ring E. Figure 2 illustrates the selectivity by comparison of the ratios of PGHS-1/PGHS-2 inhibition. Ratios > 1 are considered as preferential PGHS-1 inhibitors, ratio < 1 as preferential PGHS-2 inhibitors, a ratio = 1 as nonselective inhibitors. Oleanolic and ursolic acid have already been described as potent inhibitors of PGHS [16, 17] . In other test systems using microsomal preparations for PGHS-1 vs. pure enzyme for PGHS-2 [18] , oleanolic and ursolic acid exhibited selectivity for PGHS-2. However, in the series of triterpenoid acids isolated from Mugua, oleanolic acid did not show the best inhibitory effect against either pure PGHS-1 or PGHS-2. Oleanolic and 3β-O-acetylursolic acid were more inhibitory on PGHS-1 than on PGHS-2. The selectivity was dependent on the 19α−hydroxyl moiety, found in pomolic acid and its derivatives.
This observation could be confirmed by all isolated triterpenoid acids: all 19α-hydroxylated acids showed better inhibitory potential towards PGHS-2 than towards PGHS-1. A second hydroxyl moiety in ring A seems to intensify the preference.
Triterpenoids as prostaglandin-H-synthase inhibitors
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For high inhibitory potential, the α-amyrine-structure seems to be especially important. 3β-O-Acetylursolic acid turned out to be the most potent inhibitor. Acetylation at position 3β did not seem to influence the inhibitory potential.
Interestingly, it was shown recently that oleanolic acid induced up-regulation of COX-2 via early phosphorylation of p38 MAPK and p42/44 MAPK [19] , as was also found for alkamides of Echinacea and for the selective COX-2 inhibitor NS-398 in high concentration [20] . Oleanolic acid also induces rabbit platelet aggregation through a phospholipase C-calcium dependent signaling pathway [21] . Therefore, oleanolic acid may be considered as a modulatory compound for inflammation.
Since about 70% of the dichloromethane extract of Mugua consists of triterpenoid acids, the very good inhibitory effect of the extract seems to be the result of the activity of these different acids. It will be interesting to demonstrate whether the inhibitory potential of triterpenoid acids can be further increased by structural modification.
Experimental

Extraction and fractionation:
The plant material was provided by the TCM Hospital, Kötzting, Germany, and was identified in the Institute of Pharmaceutical Biology, Munich. A voucher specimen (12/1998) has been deposited there.
The dichloromethane extract (17.5 g) was prepared by exhaustive Soxhlet extraction of 925 g powdered Chaenomelis fruits. This extract was fractionated in two portions by vacuum liquid chromatography (VLC) with n-hexane/ethyl acetate mixtures on 180 g Silica gel (Kieselgel 60, Merck) into fractions I -X. The fractions were evaporated to dryness and [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . The purity was checked by TLC and HPLC.
Pharmacological assays: The PGHS-1 and PGHS-2 assays were performed on a microtiter scale with purified PGHS-1 from ram seminal vesicles and purified PGHS-2 from sheep placental cotyledones (both Cayman Chemical Company), as previously described [5] . The incubation mixture contained 180 µL 0.1 M tris-buffer (pH 8.0), 5 µM hematin, 18 mM epinephrin-hydrogentartrate, 0.2 U of enzyme preparation and 50 µM Na 2 EDTA (only PGHS-2 assay). Each compound solution (10 µL) was added and pre-incubated for 5 min at room temperature. The reaction was started by adding 10 µL of 5 µM arachidonic acid in EtOH p.a. and subsequent incubation at 37°C. The reaction was terminated after 20 min by adding 10 µL formic acid 10%.
Determination of PGE 2 :
The concentration of PGE 2 , the main metabolite of arachidonic acid in this reaction, was determined by a competitive PGE 2 -EIA-kit (R&D Systems), which was used as described by Reininger et al. [5] . Because of the use of alkaline phosphatase, the procedure was shortened to 2 h incubation time and 45 min for the development process, which involves pNPP (p-nitrophenyl phosphate) as a substrate. The development was stopped by adding 2N NaOH. All samples were diluted 1:15 in EIA-buffer. The EIA was evaluated by an ELISA reader 'rainbow' (Tecan Deutschland GmbH, Crailsheim, Germany) and determined as previously described [5] . Inhibition refers to reduction of PGE 2 formation in comparison with a blank without inhibitor.
NS-398 and indomethacin (both from Cayman
Chemical Company) were used as positive controls.
For testing, they were dissolved in EtOH p.a. at a concentration of 1 mM and further diluted with EtOH p.a..
Statistics:
All IC 50 values were determined for both enzymes by measuring at least three concentrations; all inhibition values are means of at least three experiments.
